La Jolla Pharmaceutical Company

LJPC NASDAQ

AlenCiken

La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe La Jolla to receive upfront cash payment of $22.5 million plus potential commercial milestone payments of up to $109.5 million and double-digit tiered royalty payments Under the terms of the exclusive licensing agreement, La...

KozakHlib

Pupm&Dump trading strategy idea. $LJPC is rising too much despite the news today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $6,20; stop-loss — $6,70; take-profit — $5,20; Do not view this idea as a recommendation for trading or...

utente_stella

A possible triangle pattern, the RSI divergence shows a nice opportunity. The stochastich suggests a good oopportunity to enter long, but it is better to wait the break-out! Comment below, I'm interested in your opinions!

Sintar123

This is actually a better wave count for LJPC. As you can see we completed 5 waves up and are currently in wave 2.

Sintar123

In wave 4 currently, going down with the rest of the market.

PennyStock101

La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401 and LJPC-0118. LJPC-501 is the proprietary formulation for angiotensin II. The...

DailyStocksPicks

Every day I pick a few stocks - the most undervalued stocks in AMEX, NYSE & NASDAQ with lowest RSI and other technical analysis (200-day moving average action and volume change), to trade for the next day. Charts for LJPC is looking great for a 1-day long play (for tomorrow) youtu.be

DailyStocksPicks

Every day I pick 2-5 stocks - the most undervalued stocks in AMEX, NYSE & NASDAQ with lowest RSI and other technical analysis (200-day moving average action and volume change), to trade for the next day. Below are my picks for Monday. LJPC charts look great for a 1-day long trade. More Details in below link youtu.be

DailyStocksPicks

I love how the chart is set up for a long position for 1-day trade. Love that it is trading at 220% of its 50-day volume average, It has been down for 3 out of past 4 days, and RSI of 10 is screaming that it is undervalued. I NASDAQ:LJPC NASDAQ:LJPC

TheChosenOnes

BullFlag

InsiderFinancial

After breaking to higher ground back in June on large volume, shares of LA JOLLA PHARMACEUTICAL CO - NASDAQ:LJPC have been drifting in a sideways pattern consolidating the move in a constructive manner as we can observe from the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, LJPC remains in decent...

OneUmbrellaGroup

Private Guidance

fhenry0331

All in the charts.

TopMarketGainers

COWAN AND CO RECENTLY ISSUED A BUY RATING AND A $25 PRICE TARGET ON NASDAQ:LJPC RESULTING IN A SPIKE IN PRICE AND VOLUME , WE EXPECT CONTINUATION IN THE DAYS AND WEEKS TO COME FOR SOME GREAT GAINS. AVERAGE ANALYSTS PRICE TARGET $19.50 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT COMPANY PROFILE La Jolla Pharmaceutical Co. operates as a biopharmaceutical...

Noxtreme

TraderNoxtreme here, Biotech Stock with positive phase 2 results. HOT setup "La Jolla Pharmaceutical Co. (LJPC) on Thursday reported positive results from the interim analysis of its phase 2 study of LJPC-401 (synthetic human hepcidin) in patients with hereditary...

RocketTickers

LJPC: La Jolla Pharmaceutical Company 2019-06-06 09:00:00 La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis - GlobeNewswire

daredorm3

nice entry point here

AcornWealthCorp

LJPC had a huge jump & now seems forming a flag formation. The flag break did not occur yet, however in hourly frame we can see that it got nice base of support in the moving averages and seems getting ready for breakout. So we would like to take a speculative entry around $34 & our target would just below $42 * Trade Criteria * Date First Found- February 28,...